etoposide has been researched along with myricetin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
He, C; He, M; Li, L; Liang, X; Luan, S; Lv, C; Song, X; Wu, Q; Yin, L; Yin, Z; Yuan, Z; Zhang, W; Zou, Y | 1 |
Bazer, FW; Lim, W; Song, G; Yang, C | 1 |
Berman, C; Emmanuel, F; Goodenow, D; Richardson, C; Sahyouni, M | 1 |
1 review(s) available for etoposide and myricetin
Article | Year |
---|---|
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.
Topics: Coumarins; Diterpenes; DNA Topoisomerases; Fatty Acids; Flavonoids; Heterocyclic Compounds; Humans; Lignans; Organometallic Compounds; Polyphenols; Quinones; Topoisomerase Inhibitors | 2019 |
5 other study(ies) available for etoposide and myricetin
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Myricetin suppresses invasion and promotes cell death in human placental choriocarcinoma cells through induction of oxidative stress.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcium Signaling; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Choriocarcinoma; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Etoposide; Female; Flavonoids; Humans; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Oxidants; Oxidative Stress; Phosphatidylinositol 3-Kinase; Pregnancy; Proto-Oncogene Proteins c-akt | 2017 |
Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
Topics: Animals; Cell Line; Chromosome Breakpoints; Chromosomes, Mammalian; Dexrazoxane; DNA; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; Etoposide; Flavonoids; Genistein; Histones; Kaempferols; Luteolin; Mice; Mouse Embryonic Stem Cells; Quercetin; Topoisomerase II Inhibitors; Translocation, Genetic | 2020 |